Develops medical devices for cancer treatment.
Jun 2026Revenue $45.1M/yrExpenses $75.6M/yr
No trendCash runway ≈ 2.0 years from Jun 2026
Figures by year
When will TriSalus Life Sciences be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $45.1M and expenses $75.6M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $45.2M | $72.1M | −$26.9M |
| Dec 2024 | $29.4M | $65.6M | −$36.2M |
| Dec 2023 | $18.5M | $73.0M | −$54.5M |
| Dec 2022 | $12.4M | $48.8M | −$36.4M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.